Armando Flor. Senior Medical Director at AstraZeneca early clinical development in CVRM (metabolism). Interested in early trials in metabolism including obesity, T2DM and steatotic liver disease, MASH and advance liver disease from different etiologies.  Trained as Pediatric Endocrinologist (NICHD) with 15 years’ experience in pharmaceutical industry.